Literature DB >> 17980511

Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors.

Isabelle Fitton1, Roel J H M Steenbakkers, Kenneth Gilhuijs, Joop C Duppen, Peter J C M Nowak, Marcel van Herk, Coen R N Rasch.   

Abstract

PURPOSE: To derive guidelines for the need to use positron emission tomography (PET) for delineation of the primary tumor (PT) according to its anatomical location in the lung. METHODS AND MATERIALS: In 22 patients with non-small-cell lung cancer, thoracic X-ray computed tomography (CT) and PET were performed. Eleven radiation oncologists delineated the PT on the CT and on the CT-PET registered scans. The PTs were classified into two groups. In Group I patients, the PT was surrounded by lung or visceral pleura, without venous invasion, without extension to chest wall or the mediastinum over more than one quarter of its surface. In Group II patients, the PT invaded the hilar region, heart, great vessels, pericardium, mediastinum over more than one quarter of its surface and/or associated with atelectasis. A comparison of interobserver variability for each group was performed and expressed as a local standard deviation.
RESULTS: The comparison of delineations showed a good reproducibility for Group I, with an average SD of 0.4 cm on CT and an average SD of 0.3 cm on CT-PET (p = 0.1628). There was also a significant improvement with CT-PET for Group II, with an average SD of 1.3 cm on CT and SD of 0.4 cm on CT-PET (p = 0.0003). The improvement was mainly located at the atelectasis/tumor interface. At the tumor/lung and tumor/hilum interfaces, the observer variation was similar with both modalities.
CONCLUSIONS: Using PET for PT delineation is mandatory to decrease interobserver variability in the hilar region, heart, great vessels, pericardium, mediastinum, and/or the region associated with atelectasis; however it is not essential for delineation of PT surrounded by lung or visceral pleura, without venous invasion or extension to the chest wall.

Entities:  

Mesh:

Year:  2007        PMID: 17980511     DOI: 10.1016/j.ijrobp.2007.08.063

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.

Authors:  Kishor Karki; Siddharth Saraiya; Geoffrey D Hugo; Nitai Mukhopadhyay; Nuzhat Jan; Jessica Schuster; Matthew Schutzer; Lester Fahrner; Robert Groves; Kathryn M Olsen; John C Ford; Elisabeth Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-06       Impact factor: 7.038

2.  Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer.

Authors:  Aleksandar Grgic; Elena Ballek; Jochen Fleckenstein; Norbert Moca; Stephanie Kremp; Andrea Schaefer; Jan-Martin Kuhnigk; Christian Rübe; Carl-Martin Kirsch; Dirk Hellwig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-22       Impact factor: 9.236

3.  Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.

Authors:  Yunfeng Cui; Wenzhou Chen; Feng-Ming Spring Kong; Lindsey A Olsen; Ronald E Beatty; Peter G Maxim; Timothy Ritter; Jason W Sohn; Jane Higgins; James M Galvin; Ying Xiao
Journal:  Pract Radiat Oncol       Date:  2014-06-30

4.  Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.

Authors:  Emma Holliday; Clifton D Fuller; Jayashree Kalpathy-Cramer; Daniel Gomez; Andreas Rimner; Ying Li; Suresh Senan; Lynn D Wilson; Jehee Choi; Ritsuko Komaki; Charles R Thomas
Journal:  J Radiat Oncol       Date:  2015-11-03

5.  Interobserver delineation variation in lung tumour stereotactic body radiotherapy.

Authors:  G F Persson; D E Nygaard; C Hollensen; P Munck af Rosenschöld; L S Mouritsen; A K Due; A K Berthelsen; J Nyman; E Markova; A P Roed; H Roed; S Korreman; L Specht
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

Review 6.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.